BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) — all Canadian products
27 DINs
18 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02526301 | BUPAQ | VETVIVA RICHTER GMBH | Solution | Intramuscular | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 0.3 MG | Marketed | |
| 02531143 | BUPRENOL | CHAMPION ALSTOE ANIMAL HEALTH INC. | Solution | Intramuscular | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 0.3 MG | Marketed | |
| 02542536 | BUPRIXA | ZOETIS CANADA INC | Solution | Intramuscular | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 0.3 MG | Approved | |
| 02424851 | PMS-BUPRENORPHINE-NALOXONE | PHARMASCIENCE INC | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 2 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 0.5 MG | Marketed | |
| 02424878 | PMS-BUPRENORPHINE-NALOXONE | PHARMASCIENCE INC | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 8 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 2 MG | Marketed | |
| 02295695 | SUBOXONE | INDIVIOR UK LIMITED | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 2 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 0.5 MG | Marketed | |
| 02295709 | SUBOXONE | INDIVIOR UK LIMITED | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 8 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 2 MG | Marketed | |
| 02468085 | SUBOXONE | INDIVIOR UK LIMITED | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 12 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 3 MG | Marketed | |
| 02468093 | SUBOXONE | INDIVIOR UK LIMITED | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 16 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 4 MG | Marketed | |
| 02502313 | SUBOXONE | INDIVIOR UK LIMITED | Film (Soluble) | Buccal; Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 2 MG; NALOXONE (NALOXONE HYDROCHLORIDE) 0.5 MG | Marketed | |
| 02502321 | SUBOXONE | INDIVIOR UK LIMITED | Film (Soluble) | Buccal; Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 4 MG; NALOXONE (NALOXONE HYDROCHLORIDE) 1 MG | Marketed | |
| 02502348 | SUBOXONE | INDIVIOR UK LIMITED | Film (Soluble) | Buccal; Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 8 MG; NALOXONE (NALOXONE HYDROCHLORIDE) 2 MG | Marketed | |
| 02502356 | SUBOXONE | INDIVIOR UK LIMITED | Film (Soluble) | Buccal; Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 12 MG; NALOXONE (NALOXONE HYDROCHLORIDE) 3 MG | Marketed | |
| 02517183 | TARO-BUPRENORPHINE/NALOXONE | TARO PHARMACEUTICALS INC | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 8 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 2 MG | Approved | |
| 02517175 | TARO-BUPRENORPHINE/NALOXONE | TARO PHARMACEUTICALS INC | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 2 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 0.5 MG | Approved | |
| 02453916 | TEVA-BUPRENORPHINE/NALOXONE | TEVA CANADA LIMITED | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 8 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 2 MG | Marketed | |
| 02453908 | TEVA-BUPRENORPHINE/NALOXONE | TEVA CANADA LIMITED | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 2 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 0.5 MG | Marketed | |
| 02342510 | VETERGESIC MULTIDOSE | CEVA ANIMAL HEALTH INC | Solution | Intramuscular | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 0.3 MG | Marketed | |
| 02465272 | BELBUCA | PURDUE PHARMA | Film (Soluble) | Buccal | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 600 MCG | Cancelled Pre Market | |
| 02465280 | BELBUCA | PURDUE PHARMA | Film (Soluble) | Buccal | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 750 MCG | Cancelled Pre Market | |
| 02465299 | BELBUCA | PURDUE PHARMA | Film (Soluble) | Buccal | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 900 MCG | Cancelled Pre Market | |
| 02465256 | BELBUCA | PURDUE PHARMA | Film (Soluble) | Buccal | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 300 MCG | Cancelled Post Market | |
| 02465264 | BELBUCA | PURDUE PHARMA | Film (Soluble) | Buccal | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 450 MCG | Cancelled Post Market | |
| 02465221 | BELBUCA | PURDUE PHARMA | Film (Soluble) | Buccal | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 75 MCG | Cancelled Post Market | |
| 02465248 | BELBUCA | PURDUE PHARMA | Film (Soluble) | Buccal | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 150 MCG | Cancelled Post Market | |
| 02408090 | MYLAN-BUPRENORPHINE/NALOXONE | MYLAN PHARMACEUTICALS ULC | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 2 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 0.5 MG | Cancelled Post Market | |
| 02408104 | MYLAN-BUPRENORPHINE/NALOXONE | MYLAN PHARMACEUTICALS ULC | Tablet | Sublingual | BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE) 8 MG; NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE) 2 MG | Cancelled Post Market |
Browse other molecules: